Literature DB >> 28916386

Molecular Mechanisms of the R61T Mutation in Apolipoprotein E4: A Dynamic Rescue.

Benfeard Williams1, Marino Convertino1, Jhuma Das1, Nikolay V Dokholyan2.   

Abstract

The apolipoprotein E4 (ApoE4) gene is the strongest genetic risk factor for Alzheimer's disease (AD). With respect to the other common isoforms of this protein (ApoE2 and ApoE3), ApoE4 is characterized by lower stability that underlies the formation of a stable interaction between the protein's N- and C-terminal domains. AD-related cellular dysfunctions have been linked to this ApoE4 misfolded state. In this regard, it has been reported that the mutation R61T is able to rescue the deleterious cellular effects of ApoE4 by preventing the formation of the misfolded intermediate state. However, a clear description of the structural features at the basis of the R61T-ApoE4 mutant's protective effect is still missing. Recently, using extensive molecular dynamics simulations, we have identified a structural model of an ApoE4 misfolded intermediate state. Building on our previous work, here we explore the dynamical changes induced by the R61T mutation in the ApoE4 native and misfolded states. Notably, we do not observe any local changes in the domains in the R61T-ApoE4 system, rather a general loss of correlated movements in the entire protein structure. More specifically, we detect increased dynamics in the hinge region, which is essential for ApoE4 domain-domain interaction. Consistent with previously reported data on altered phospholipid and receptor binding, we hypothesize that mutations destabilizing the ApoE4 intermediate state change hinge region dynamics, which propagates to distal functional regions of the protein and modifies ApoE4's functional properties. This unique behavior of the ApoE4 hinge region provides, to our knowledge, a novel understanding of ApoE4's role in AD.
Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28916386      PMCID: PMC5700245          DOI: 10.1016/j.bpj.2017.08.026

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  43 in total

1.  Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer.

Authors:  Qin Xu; Walter J Brecht; Karl H Weisgraber; Robert W Mahley; Yadong Huang
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

2.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.

Authors:  Shiming Ye; Yadong Huang; Karin Müllendorff; Liming Dong; Gretchen Giedt; Elaine C Meng; Fred E Cohen; Irwin D Kuntz; Karl H Weisgraber; Robert W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

4.  Concerning the structure of apoE.

Authors:  Carl Frieden; Kanchan Garai
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

5.  Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.

Authors:  Palaniappan S Chetty; Leland Mayne; Sissel Lund-Katz; S Walter Englander; Michael C Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein.

Authors:  S Bodovitz; W L Klein
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

Review 7.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

8.  Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.

Authors:  Hung-Kai Chen; Zhaoping Liu; Anke Meyer-Franke; Jens Brodbeck; Rene D Miranda; James G McGuire; Michael A Pleiss; Zhong-Sheng Ji; Maureen E Balestra; David W Walker; Qin Xu; Dah-eun Jeong; Madhu S Budamagunta; John C Voss; Stephen B Freedman; Karl H Weisgraber; Yadong Huang; Robert W Mahley
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

9.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; M Goedert; K H Weisgraber; L M Dong; R Jakes; D Y Huang; M Pericak-Vance; D Schmechel; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Ab initio folding of proteins with all-atom discrete molecular dynamics.

Authors:  Feng Ding; Douglas Tsao; Huifen Nie; Nikolay V Dokholyan
Journal:  Structure       Date:  2008-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.